BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35469452)

  • 1. Ovarian failure risk in post-pubertal patients with cancer: a prognostic model.
    Cioffi R; Fais ML; Bergamini A; Vanni VS; Pagliardini L; Papaleo E; Mangili G; Candiani M
    Future Oncol; 2022 Jun; 18(19):2391-2400. PubMed ID: 35469452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond fertility preservation: role of the oncofertility unit in the reproductive and gynecological follow-up of young cancer patients.
    Massarotti C; Scaruffi P; Lambertini M; Sozzi F; Remorgida V; Anserini P
    Hum Reprod; 2019 Aug; 34(8):1462-1469. PubMed ID: 31339999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal study of AMH variations in 122 Adolescents and Young Adults (AYA) and non-AYA lymphoma patients to evaluate the chemo-induced ovarian toxicity to further personalise fertility preservation counselling.
    Decanter C; Delepine J; Behal H; Manier S; Bruno B; Barbatti M; Robin C; Labreuche J; Morschhauser F; Pigny P
    Hum Reprod; 2021 Sep; 36(10):2743-2752. PubMed ID: 34417822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproductive function assessment after surgery plus chemotherapy for germ cell ovarian tumors (MOGCT): novel clues deriving from the field of fertility preservation.
    Ottolina J; Mangili G; Sigismondi C; Vanni VS; Viganò P; Candiani M
    Gynecol Endocrinol; 2014 Nov; 30(11):778-80. PubMed ID: 25034573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy-based gonadotoxicity risk evaluation as a predictor of reproductive outcomes in post-pubertal patients following ovarian tissue cryopreservation.
    Karavani G; Rottenstreich A; Schachter-Safrai N; Cohen A; Weintraub M; Imbar T; Revel A
    BMC Womens Health; 2021 May; 21(1):201. PubMed ID: 33985473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysis.
    Munhoz RR; Pereira AA; Sasse AD; Hoff PM; Traina TA; Hudis CA; Marques RJ
    JAMA Oncol; 2016 Jan; 2(1):65-73. PubMed ID: 26426573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and usefulness of cryopreservation of ovarian tissue to preserve fertility: a 12-year retrospective analysis.
    Imbert R; Moffa F; Tsepelidis S; Simon P; Delbaere A; Devreker F; Dechene J; Ferster A; Veys I; Fastrez M; Englert Y; Demeestere I
    Hum Reprod; 2014 Sep; 29(9):1931-40. PubMed ID: 24958067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian function, fertility, and menopause occurrence after fertility-sparing surgery and chemotherapy for ovarian neoplasms.
    Ceppi L; Galli F; Lamanna M; Magni S; Dell'Orto F; Verri D; Delle Marchette M; Lissoni AA; Sina F; Giuliani D; Grassi T; Landoni F; Bonazzi CM; Fruscio R
    Gynecol Oncol; 2019 Feb; 152(2):346-352. PubMed ID: 30578004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study.
    Lambertini M; Fontana V; Massarotti C; Poggio F; Dellepiane C; Iacono G; Abate A; Miglietta L; Ferreccio C; Pescio MC; Conte B; Blondeaux E; Bighin C; D'Alonzo A; Vaglica M; Zanardi E; Boccardo F; Ballestrero A; Anserini P; Del Mastro L
    Breast; 2018 Oct; 41():51-56. PubMed ID: 30007268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian function in female survivors after multimodal Ewing sarcoma therapy.
    Raciborska A; Bilska K; Filipp E; Drabko K; Rogowska E; Chaber R; Pogorzała M; Połczyńska K; Adrianowska N; Rodriguez-Galindo C; Maciejewski T
    Pediatr Blood Cancer; 2015 Feb; 62(2):341-345. PubMed ID: 25399867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncofertility outcomes after fertility-sparing treatment of bilateral serous borderline ovarian tumors: results of a large retrospective study.
    Jia SZ; Xiang Y; Yang JJ; Shi JH; Jia CW; Leng JH
    Hum Reprod; 2020 Feb; 35(2):328-339. PubMed ID: 32048711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.
    Abir R; Ben-Aharon I; Garor R; Yaniv I; Ash S; Stemmer SM; Ben-Haroush A; Freud E; Kravarusic D; Sapir O; Fisch B
    Hum Reprod; 2016 Apr; 31(4):750-62. PubMed ID: 26848188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for fertility preservation in young early breast cancer patients.
    Tomasi-Cont N; Lambertini M; Hulsbosch S; Peccatori AF; Amant F
    Breast; 2014 Oct; 23(5):503-10. PubMed ID: 24934638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response.
    Volodarsky-Perel A; Cohen Y; Arab S; Son WY; Suarthana E; Dahan MH; Tulandi T; Buckett W
    Hum Reprod; 2019 Mar; 34(3):530-538. PubMed ID: 30689898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic ovarian preservation in young women undergoing chemotherapy.
    Chahvar ST; Al-Shawaf T; Tranquilli AL
    Curr Med Chem; 2014; 21(2):223-9. PubMed ID: 24164203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-growing follicle density is increased following adriamycin, bleomycin, vinblastine and dacarbazine (ABVD) chemotherapy in the adult human ovary.
    McLaughlin M; Kelsey TW; Wallace WH; Anderson RA; Telfer EE
    Hum Reprod; 2017 Jan; 32(1):165-174. PubMed ID: 27923859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian damage from chemotherapy and current approaches to its protection.
    Spears N; Lopes F; Stefansdottir A; Rossi V; De Felici M; Anderson RA; Klinger FG
    Hum Reprod Update; 2019 Nov; 25(6):673-693. PubMed ID: 31600388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of first-line cancer treatment on the follicle quality in cryopreserved ovarian samples from girls and young women.
    Pampanini V; Wagner M; Asadi-Azarbaijani B; Oskam IC; Sheikhi M; Sjödin MOD; Lindberg J; Hovatta O; Sahlin L; Björvang RD; Otala M; Damdimopoulou P; Jahnukainen K
    Hum Reprod; 2019 Sep; 34(9):1674-1685. PubMed ID: 31411325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian reserve and response to IVF and in vitro maturation treatment following chemotherapy.
    Das M; Shehata F; Son WY; Tulandi T; Holzer H
    Hum Reprod; 2012 Aug; 27(8):2509-14. PubMed ID: 22617122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The unmet need for oncofertility preservation in women: Results of a survey by different oncological specialists in Lazio, Italy.
    Fabi A; Lanzetta G; Vizza E; Corsi D; Moscetti L; Spinelli G; Mentuccia L; Lalle M; Perrone M; Baiocco L; Falcicchio C; Milani A; Giannarelli D; Cognetti F; Pugliese P
    Curr Probl Cancer; 2019 Dec; 43(6):100479. PubMed ID: 31126661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.